Home
Forums
New posts
Contact Us
What's new
New posts
New media
New media comments
Latest activity
Media
New media
New comments
Search media
Search All
Members
Current visitors
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Contact Us
Menu
Log in
Register
Install the app
Install
Forums
Really good
Travel
FDA approves antibacterial drug to treat travelers' diarrhea
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="cheryl" data-source="post: 669" data-attributes="member: 1"><p><a href="https://www.news-medical.net/news/20181117/FDA-approves-antibacterial-drug-to-treat-travelers-diarrhea.aspx" target="_blank"><strong>FDA approves antibacterial drug to treat travelers' diarrhea - News-Medical</strong></a></p><p></p><p>The U.S. Food and Drug Administration today approved Aemcolo (rifamycin), an antibacterial drug indicated for the treatment of adult patients with travelers' diarrhea caused by noninvasive strains of <em>Escherichia coli</em> (<em>E. coli</em>), not complicated by fever or blood in the stool.</p><p></p><p>"Travelers' diarrhea affects millions of people each year and having treatment options for this condition can help reduce symptoms of the condition," said Edward Cox, M.D., M.P.H., director of the Office of Antimicrobial Products in the FDA's Center for Drug Evaluation and Research.</p><p></p><p>Travelers' diarrhea is the most common travel-related illness, affecting an estimated 10 to 40 percent of travelers worldwide each year. Travelers' diarrhea is defined by having three or more unformed stools in 24 hours, in a person who is traveling. It is caused by a variety of pathogens, but most commonly bacteria found in food and water. The highest-risk destinations are in most of Asia as well as the Middle East, Africa, Mexico, and Central and South America.</p></blockquote><p></p>
[QUOTE="cheryl, post: 669, member: 1"] [URL='https://www.news-medical.net/news/20181117/FDA-approves-antibacterial-drug-to-treat-travelers-diarrhea.aspx'][B]FDA approves antibacterial drug to treat travelers' diarrhea - News-Medical[/B][/URL] The U.S. Food and Drug Administration today approved Aemcolo (rifamycin), an antibacterial drug indicated for the treatment of adult patients with travelers' diarrhea caused by noninvasive strains of [I]Escherichia coli[/I] ([I]E. coli[/I]), not complicated by fever or blood in the stool. "Travelers' diarrhea affects millions of people each year and having treatment options for this condition can help reduce symptoms of the condition," said Edward Cox, M.D., M.P.H., director of the Office of Antimicrobial Products in the FDA's Center for Drug Evaluation and Research. Travelers' diarrhea is the most common travel-related illness, affecting an estimated 10 to 40 percent of travelers worldwide each year. Travelers' diarrhea is defined by having three or more unformed stools in 24 hours, in a person who is traveling. It is caused by a variety of pathogens, but most commonly bacteria found in food and water. The highest-risk destinations are in most of Asia as well as the Middle East, Africa, Mexico, and Central and South America. [/QUOTE]
Verification
Post reply
Forums
Really good
Travel
FDA approves antibacterial drug to treat travelers' diarrhea
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top